Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Resgen Granted 30 Year Mining Right at Boikarabelo

Residents Say Stop Mountaintop Removal in Virginia

Rio Tinto Now Owns 72% of Riversdale Mining

Cadan Resources Completes Definition Drilling at Comval Property

Indicator Minerals Begins 5,000m Drilling Program at Mohave Copper Project

Bravada Gold Starts Core Drilling at East Manhattan Project, Nevada

Ranger Gold Obtains Approval for Drilling at CX Project

Western Sierra Mining Signs Tentative Agreement to Expand Silver Cord Mine

Quadra FNX Mining Discovers High Grade Copper at Sudbury

Namibia Expecting $3.5 Billion Mining Investments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.